Upregulation of XRN2 acts as an oncogene in oral squamous cell carcinoma and correlates with poor prognosis
CONCLUSION: XRN2 is significantly overexpressed in OSCC tissues and its upregulation was closely associated with poor prognosis of OSCC patients. XRN2 could be a useful prognostic biomarker and a potential therapeutic target for OSCC.PMID:33626405 | DOI:10.1016/j.prp.2021.153355
Source: Pathology, Research and Practice - Category: Pathology Authors: Jia-Cheng Liu Ling Gao Shao-Ming Li Jing-Jing Zheng Da-Gang Li Ke-Qian Zhi Wen-Hao Ren Source Type: research
More News: Cancer & Oncology | Carcinoma | Databases & Libraries | Epithelial Cancer | Oral Cancer | Pathology | Skin Cancer | Squamous Cell Carcinoma